189 related articles for article (PubMed ID: 24460759)
1. Influence of type-I Interferon receptor expression level on the response to type-I Interferons in human pancreatic cancer cells.
Booy S; van Eijck CH; Dogan F; van Koetsveld PM; Hofland LJ
J Cell Mol Med; 2014 Mar; 18(3):492-502. PubMed ID: 24460759
[TBL] [Abstract][Full Text] [Related]
2. Type I interferons in the treatment of pancreatic cancer: mechanisms of action and role of related receptors.
Vitale G; van Eijck CH; van Koetsveld Ing PM; Erdmann JI; Speel EJ; van der Wansem Ing K; Mooij DM; Colao A; Lombardi G; Croze E; Lamberts SW; Hofland LJ
Ann Surg; 2007 Aug; 246(2):259-68. PubMed ID: 17667505
[TBL] [Abstract][Full Text] [Related]
3. IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro.
Vitale G; de Herder WW; van Koetsveld PM; Waaijers M; Schoordijk W; Croze E; Colao A; Lamberts SW; Hofland LJ
Cancer Res; 2006 Jan; 66(1):554-62. PubMed ID: 16397272
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibitory effects of type I interferons on human adrenocortical carcinoma cell growth.
van Koetsveld PM; Vitale G; de Herder WW; Feelders RA; van der Wansem K; Waaijers M; van Eijck CH; Speel EJ; Croze E; van der Lely AJ; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2006 Nov; 91(11):4537-43. PubMed ID: 16912135
[TBL] [Abstract][Full Text] [Related]
5. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
6. Synergistic antitumor effect of interferon-ß with gemcitabine in interferon-α-non-responsive pancreatic cancer cells.
Tomimaru Y; Eguchi H; Wada H; Tomokuni A; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Mori M; Doki Y; Nagano H
Int J Oncol; 2011 May; 38(5):1237-43. PubMed ID: 21347515
[TBL] [Abstract][Full Text] [Related]
7. Response of pancreatic cancer cells treated with interferon-alpha or beta and co-exposed to ionising radiation.
Jöst E; Roos WP; Kaina B; Schmidberger H
Int J Radiat Biol; 2010 Sep; 86(9):732-41. PubMed ID: 20586542
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor.
da Silva AJ; Brickelmaier M; Majeau GR; Lukashin AV; Peyman J; Whitty A; Hochman PS
J Interferon Cytokine Res; 2002 Feb; 22(2):173-88. PubMed ID: 11911800
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of type III interferon alone or in combination with type I interferon against human non-small cell lung cancer.
Fujie H; Tanaka T; Tagawa M; Kaijun N; Watanabe M; Suzuki T; Nakayama K; Numasaki M
Cancer Sci; 2011 Nov; 102(11):1977-90. PubMed ID: 21883692
[TBL] [Abstract][Full Text] [Related]
10. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
[TBL] [Abstract][Full Text] [Related]
11. Type I Interferon Receptor Expression in Human Pancreatic and Periampullary Cancer Tissue.
Booy S; Hofland LJ; Waaijers AM; Croze E; van Koetsveld PM; de Vogel L; Biermann K; van Eijck CH
Pancreas; 2015 Jan; 44(1):99-105. PubMed ID: 25072284
[TBL] [Abstract][Full Text] [Related]
12. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.
Singh RK; Gutman M; Bucana CD; Sanchez R; Llansa N; Fidler IJ
Proc Natl Acad Sci U S A; 1995 May; 92(10):4562-6. PubMed ID: 7753843
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.
Trinh KR; Vasuthasawat A; Steward KK; Yamada RE; Timmerman JM; Morrison SL
J Immunother; 2013 Jun; 36(5):305-18. PubMed ID: 23719241
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death.
Zhang KX; Matsui Y; Hadaschik BA; Lee C; Jia W; Bell JC; Fazli L; So AI; Rennie PS
Int J Cancer; 2010 Aug; 127(4):830-8. PubMed ID: 19957332
[TBL] [Abstract][Full Text] [Related]
15. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha.
Rani MR; Foster GR; Leung S; Leaman D; Stark GR; Ransohoff RM
J Biol Chem; 1996 Sep; 271(37):22878-84. PubMed ID: 8798467
[TBL] [Abstract][Full Text] [Related]
16. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
17. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
[TBL] [Abstract][Full Text] [Related]
18. Differential responsiveness to IFN-alpha and IFN-beta of human mature DC through modulation of IFNAR expression.
Severa M; Remoli ME; Giacomini E; Ragimbeau J; Lande R; Uzé G; Pellegrini S; Coccia EM
J Leukoc Biol; 2006 Jun; 79(6):1286-94. PubMed ID: 16624932
[TBL] [Abstract][Full Text] [Related]
19. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
Zaritsky LA; Bedsaul JR; Zoon KC
J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
[TBL] [Abstract][Full Text] [Related]
20. Effects of interferons α/β on the proliferation of human micro- and macrovascular endothelial cells.
Erdmann J; Vitale G; van Koetsveld PM; Croze E; Sprij-Mooij DM; Hofland LJ; van Eijck CH
J Interferon Cytokine Res; 2011 May; 31(5):451-8. PubMed ID: 21361792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
